NewAmsterdam Pharma Company N.V. (NAMS) short interest & options flow
NASDAQNewAmsterdam Pharma heads into the autumn with a curious split: short interest has risen sharply over the past month while the options market has turned markedly less bearish — two signals pointing in opposite directions on a stock already down 8% in a month. The short side tells a clear story of accumulating pressure. Short interest has climbed 38% in a month, reaching 11.2% of…
NAMS short interest surges 20.2% in one week to 8.1% of float, driven by biotech volatility and pipeline catalysts.
- Market cap
- $2.26B
- Next earnings
- 18 Feb 2027
Key data as of 8 Nov 2026
Latest signals on NAMS
- Short Interest
NAMS short interest surges 20.2% in one week to 8.1% of float, driven by biotech volatility and pipeline catalysts.
NAMS news and analysis
RSSNo long-form analysis yet for NAMS. Pulse alerts and the live data picture are available on ORTEX.
Open NAMS on ORTEX →Want the live picture for NAMS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NAMS — free to start on ORTEX.
Sign up for free →Open NAMS on ORTEX